Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Promyelocytic, Acute 2

Interventions

Tretinoin 2Arsenic Trioxide 2arsenous acid 1Mitoxantrone 1Methotrexate 1Mercaptopurine 1Lisaftoclax 1Idarubicin 1Gemtuzumab 1Cytarabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Promyelocytic, Acute × Arsenic Trioxide × 30 days × Clear all
NCT02688140 2026-05-29

TUD-APOLLO-064

Technische Universität Dresden

Phase 3 Completed
133 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

NCT01409161 2026-05-20

Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia

M.D. Anderson Cancer Center

Phase 2 Recruiting
151 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡